8. MATERIALS AND METHODS
8.6.6 Methodology of TIMP-1 and MMP-
8.6.6.1 Immunohistochemistry and immunological methods
%EEMFG@AKLG;@=EA;9D KL9AFAF? G> 0%), 9F< )), O=J= 9F9DQR=< >JGE 0):DG;CK)GFG;DGF9DEGMK=%?#. /QKL=EK ) )AFF=9HGDAK 1/ O9K MK=< 9K 9 HJAE9JQ 9FLA:G<Q >GJ 0%), 9F9DQKAK "GJ AEEMFG@AKLG;@=EA;9D 9F9DQKAK G>)), 9 KH=;A>A; HGDQ;DGF9D J9::AL 9FLA @ME9F)),O9KMK=<9KL@=HJAE9JQ9FLA:G<Q "GJ:GL@0%), 9F<)), 9KDA<=AF<ADM=FLOAL@GMLHJAE9JQ9FLA:G<Q9F<?AF?AN9DLAKKM= O=J=MK=<9KF=?9LAN=9F<HGKALAN=;GFLJGDK J=KH=;LAN=DQ
0MEGJ 9F< KLJGE9D ;=DDK AF L@= 0) KDA<=K O=J= K;GJ=< K=H9J9L=DQ :Q LOG J=K=9J;@=JK0AEG9JHTF9F<&99F9$9?KLJUE0@=K;GJAF?G>)),9F< 0%), AF LMEGJ LAKKM= 9F< AF L@= AF>D9EE9LGJQ ;=DDK O=J= =N9DM9L=< 9;;GJ<AF?LGL@=FME:=JG>HGKALAN=;=DDK9K>GDDGOKF=?9LAN= HGKALAN= ;=DDK HGKALAN=;=DDK 9F<HGKALAN=;=DDKH=J0)KHGL
8.6.6.2 Serum analyses
DGG< K9EHD=K O=J= ;GDD=;L=< HJGKH=;LAN=DQ 9F< L@=F >GDDGO=< :Q K=JME =PLJ9;LAGF:Q;=FLJA>M?9LAGF9L?>GJEAFML=K>L=J;=FLJA>M?9LAGF K=J9 O=J=KLGJ=<9LV%")O9KMK=<LG<=L=JEAF=)),K=JMED=N=DK9F< 9F!(%/CAL#!$=9DL@;9J=1'(AEAL=< M;CAF?@9EK@AJ= 1'O9KMK=<LG 9KK=KK0%),K=JMED=N=DK/=JMED=N=DK9J=HJ=K=FL=<9KHEGDDH)
8.7 Statistical analyses
DD KL9LAKLA;9D 9F9DQK=K O=J= H=J>GJE=< OAL@ %) /,// /L9LAKLA;K %) /GE=JK %( 1/ ;GEH9JAKGF G> E=<A9FK G> ;GFLAFMGMK N9JA9:D=K OAL@ ;9L=?GJA;9DN9JA9:D=KO9KH=J>GJE=<MKAF?)9FF3@ALF=Q1L=KL9F<'JMKC9D 39DDAKL=KLO@=FKMAL9:D=0@=LOGK9EHD=LL=KLO9KMK=<LG;GEH9J=E=9FK G> FGJE9DDQ <AKLJA:ML=< ;GFLAFMGMK N9JA9:D=K :=LO==F LOG AF<=H=F<=FL ?JGMHK@AKIM9J=<9F<"AK@=J’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
.+ ;MJN=K 9F< 5GM<=F AF<=P K=FKALANALQKH=;A>A;ALQ O=J= MK=< LG <=L=JEAF=L@=GHLAE9D;MLG>>K=JMED=N=DG>0%),LG<AKLJA:ML=H9LA=FLKAFLG LOG?JGMHKG>:=LL=J9F<HGGJ=JKMJNAN9D/MJNAN9D;MJN=KO=J=<J9OFMKAF?L@= '9HD9F)=A=JE=L@G</L9LAKLA;9DKA?FA>A;9F;=AF'9HD9F)=A=J=KLAE9L=KO=J= ;9D;MD9L=<OAL@L@=DG?J9FCL=KLLOGKA<=<N9DM=O9K9KK=KK=<9K L@=KL9LAKLA;9DD=N=DG>KA?FA>A;9F;=AF9DDKLM<A=K
8.8 Ethical considerations
DDKLM<Q<=KA?FK>GDDGO=<L@=?MA<=DAF=K9F<D=?AKD9LAGFG>L@= =;D9J9LAGFG> $=DKAFCA 0@= KLM<Q <=KA?F 9F< H=JEAKKAGF O=J= 9HHJGN=< :Q L@= .=K=9J;@ !L@A;KG9J<G>L@=$GKHAL9D AKLJA;LG>$=DKAFCA9F<1MKAE99 "AFD9F< FJ
%F>GJE=<;GFK=FLOAL@9OJALL=FKA?F9LMJ=O9KG:L9AF=<>JGE9DDH9LA=FLKO@G H9JLA;AH9L=< AF /LM<Q 2 0@AK AF;DM<=< H=JEAKKAGF LG MK= HJAE9JQ +,/ K9EHD=K 9F< LG G:L9AF :DGG< K9EHD=K >JGE H9JLA;AH9FLK >GJ >MJL@=J KLM<Q HMJHGK=K